Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Head & Neck 3CNS 1Breast 1

Conditions

Brain Neoplasms 19Breast Neoplasms 14Glioblastoma 4Squamous Cell Carcinoma of Head and Neck 3Salivary Gland Neoplasms 3Neoplasm Metastasis 3Esthesioneuroblastoma, Olfactory 3Stomach Neoplasms 2Neoplasms 2Meningeal Neoplasms 2Meningeal Carcinomatosis 2Head and Neck Neoplasms 2Glioma 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Bile Duct Neoplasms 2Astrocytoma 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms, Unknown Primary 1Liver Neoplasms 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Appendiceal Neoplasms 1

Interventions

Temozolomide 23Bevacizumab 18Cyclophosphamide 9Carboplatin 7Lomustine 6Irinotecan 63-Iodobenzylguanidine 6Topotecan 5Radiotherapy 5Filgrastim 5Radiosurgery 4Nivolumab 4Everolimus 4Etoposide 4Busulfan 4sonidegib 3pembrolizumab 3olaparib 3fludarabine phosphate 3fludarabine 3antineoplaston AS 2-1 3antineoplaston A10 3Vincristine 3Thiotepa 3Sirolimus 3Melphalan 3IL13-PE38 3Drug Therapy 3Antilymphocyte Serum 3verubulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Capecitabine × CNS × Clear all
NCT02669173 2026-02-23

Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

Case Comprehensive Cancer Center

Phase 1 Completed
12 enrolled
CNS

Brain Neoplasms, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡